Erik Atkisson
Compliance Officer bei RAIN ONCOLOGY INC.
Vermögen: 1 001 $ am 31.03.2024
Profil
Erik Atkisson is currently the General Counsel & Chief Compliance Officer at Rain Oncology, Inc. Prior to this, he was the Chief Compliance Officer at Cytokinetics, Inc. He also served as the Secretary & General Counsel at Eiger BioPharmaceuticals, Inc. from 2021 to 2023.
Mr. Atkisson received his undergraduate degree from Harvard University, his graduate degree from The University of Edinburgh, and his law degree from Georgetown University Law Center.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
26.01.2023 | 200 ( 0,01% ) | 1 001 $ | 31.03.2024 |
Aktive Positionen von Erik Atkisson
Unternehmen | Position | Beginn |
---|---|---|
RAIN ONCOLOGY INC. | Compliance Officer | - |
Ehemalige bekannte Positionen von Erik Atkisson
Unternehmen | Position | Ende |
---|---|---|
EIGER BIOPHARMACEUTICALS, INC. | Compliance Officer | 13.04.2023 |
CYTOKINETICS, INCORPORATED | Compliance Officer | - |
Ausbildung von Erik Atkisson
Harvard University | Undergraduate Degree |
The University of Edinburgh | Graduate Degree |
Georgetown University Law Center | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
CYTOKINETICS, INCORPORATED | Health Technology |
EIGER BIOPHARMACEUTICALS, INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
Rain Oncology, Inc.
Rain Oncology, Inc. BiotechnologyHealth Technology Rain Oncology, Inc. is a clinical-stage precision oncology company, which focuses on developing and implement the precision oncology therapies for patients suffering from cancer. The company was founded by Avanish Vellanki and Robert Doebele in April 2017 and is headquartered in Newark, CA. | Health Technology |